Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A

Status Recruiting

Clinical Trial Summary

Ultrasound (US) as first-line imaging technology in detecting focal liver lesions,also plays a crucial role in evaluating image and guiding ablation which is the main treatment for liver lesions. However, the effect of US in diagnosing liver lesions is challenged by several factors including being highly dependent on doctor's experience, low signal-to-noise ratio, low resolution for lesion feature,large error from thermal field evaluation during the process of ablation and so on. Therefore, it is of great significance to construct an intelligent US analysis system depending on the digital information technology. Basing on these problems,the following research will be involved in our project: 1) US database of liver lesions with seamless connection to Picture Archiving and Communication Systems (PACS) will be developed, with the aim to provide standard data for intelligent US analysis. 2) Deep learning model for accurate segmentation, detection and classification of liver lesions on US images will be studied. Then automatic extraction, selection and analysis of liver lesion ultrasound features and the intelligent US diagnosis for liver lesions will be realized. 3) Proposing a clustering model with deep image features, and depicting the similarity measurement of liver cancer, which can be furthered used to link the liver cancer feature to optimal ablation parameters. The intelligent decision-making system for quantifying thermal ablation will be established. 4) Regression algorithm and Generative Adversarial Nets will be developed to extract the image features of liver cancer which will predict risk factors after US-guided thermal ablation.Based on the above researches, it is of great value to establish an intelligent focal liver lesion US diagnosis system involving intelligent diagnosis,personalized ablation strategy and accurate prognosis evaluation, improving the level of accurate diagnosis and treatment of liver lesions.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03871140
Study type	Observational
Source	Chinese PLA General Hospital
Contact	Jie Yu, Dr
Phone	15901417963
Email	jiemi301@163.com
Status	Recruiting
Phase
Start date	January 1, 2017
Completion date	December 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05073744` - Nalbuphine Versus Morphine for Perioperative Tumor Ablation	Phase 4
Active, not recruiting	`NCT05270642` - Plan for Microwave Thermal Field	N/A
Recruiting	`NCT03591627` - Left Atrial Thrombus on Transesophageal Echocardiography
Completed	`NCT04293198` - Evaluating the Performance of the KODEX-EPD CRyOballoon Occlusion Feature in Patients With Atrial Fibrillation
Terminated	`NCT01546168` - Deviating the Esophagus in Atrial Fibrillation Ablation	N/A
Not yet recruiting	`NCT05848635` - Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled	Phase 4
Recruiting	`NCT05698576` - TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer	N/A
Completed	`NCT05498779` - Ablation of Hepatocellular Carcinoma: a Nationwide Study
Enrolling by invitation	`NCT04893278` - Virtual Reality in Electrophysiology Laboratory (EP)
Not yet recruiting	`NCT01833286` - TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma	Phase 3
Recruiting	`NCT01229306` - Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation	N/A
Completed	`NCT03844841` - The Deep Sedation for Ablation Study	Phase 4
Recruiting	`NCT03249545` - Late Effect of Ablation on Premature Ventricular Complex Ablation	N/A
Completed	`NCT01229033` - Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF	N/A
Recruiting	`NCT06134739` - Arterial Embolism After Catheter Ablation of Atrial Fibrillation. ATRIAL FIBRILLATION
Recruiting	`NCT06172699` - Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Recruiting	`NCT05257694` - Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning
Not yet recruiting	`NCT06231160` - Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic Cancer
Completed	`NCT01896219` - CTNAV II : Multicentric Evaluation of IMACTIS-CT Navigation System	N/A
Active, not recruiting	`NCT04046354` - Microwave vs. Radiofrequency Ablation for Benign Thyroid Nodules: A Multicenter Randomized Controlled Trial Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms